Skip to main content
Clinical Trials/NCT02306603
NCT02306603
Recruiting
Not Applicable

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Duodenum and Ampulla

Professor Michael Bourke1 site in 1 country200 target enrollmentOctober 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Adenoma, Villous
Sponsor
Professor Michael Bourke
Enrollment
200
Locations
1
Primary Endpoint
Observed procedural data: Number of Participants with Adverse Events as a Measure of Safety and Tolerability Outcomes
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This research project, 'Outcomes of endoscopic resection of mucosal and submucosal lesions in the duodenum and ampulla'. The research project is aiming to determine the most effective and safe way to remove such lesions.

Detailed Description

Endoscopic resection (ER) of superficial lesions of the duodenum and ampulla is a safe and effective surgery sparing modality in experienced hands. It is often curative of dysplastic lesions and is associated with minimal complications and high patient acceptance (1-5). Westmead Hospital has accumulated a significant amount of experience in the removal of such lesions; however, there is limited research to document the long term outcomes of patients undergoing endoscopic resection.The purpose of this study is to evaluate the long-term outcomes of ER of superficial lesions of the duodenum and ampulla.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
April 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Professor Michael Bourke
Responsible Party
Sponsor Investigator
Principal Investigator

Professor Michael Bourke

Director of Gastrointestinal Endoscopy

Western Sydney Local Health District

Eligibility Criteria

Inclusion Criteria

  • \* Duodenal and ampullary lesion \> 10mm
  • Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
  • Aged 18 years or older

Exclusion Criteria

  • Lesion less than 10mm
  • Duodenal or ampullary lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
  • Aged younger than 18 years

Outcomes

Primary Outcomes

Observed procedural data: Number of Participants with Adverse Events as a Measure of Safety and Tolerability Outcomes

Time Frame: 14 days

Secondary Outcomes

  • Analysis of the costs of this procedure compared to previous treatments(14 days)

Study Sites (1)

Loading locations...

Similar Trials